The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

War in Ukraine: The nuclear threat increases

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

With the Russian invasion stalled and with a forceful counter-attack by Ukrainian armed forces, many observers caution that the Kremlin might be considering a show of force much as the U.S. did in the atomic bombings of Hiroshima and Nagasaki (The Cancer Letter, Feb. 25, March 4, March 11, 2022). 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London
Table of Contents

YOU MAY BE INTERESTED IN

U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
By Matthew Bin Han Ong
Byline
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account